foxo4-dri longecity Peptide FOX04-DRI (Anti-Aging & Senescent Cell
Description
How does Dihexa cross the blood-brain barrier more effectively than other peptides? Dihexa achieves 0.87% injected dose per gram brain tissue in pharmacokinetic models nearly 10-fold higher than typical peptide-based neuroactive compounds, which average less than 0.1% brain uptake due to size exclusion at endothelial tight junctions
10.1093/ndt/gfab191 6 BarrattJ.SulowiczW.SchmigM.EspositoC.ReuschM.YoungJ.et al (2021b)
at least not yet, or perhaps not ever
Under these conditions, lyophilized BPC-157 remains stable for 12-24 months
Novo Nordisk, the owner of the Ozempic and Wegovy GLP-1 drugs, has announced a deal to work with a Californian biotech firm on a weight-loss implant
